On May 27, 2025, the National Down Syndrome Society (NDSS) sent a letter to Senate Majority Leader Thune, Majority Whip Barrasso, Democratic Leader Schumer, and Democratic Whip Durbin, calling for the rapid passage of the Ensuring Pathways to Innovative Cures (EPIC) Act (S. 832/H.R. 1492). If passed, this bipartisan bill would ensure that small-molecule drugs such as pills, tablets, and patches receive equal priority in research and funding compared to more invasive treatment options.
As President Trump's recent executive order acknowledges, incentivizing research into small-molecule therapies is critical for communities with disabilities - particularly those in rural areas or with mobility challenges. NDSS encourages Senate leadership to take swift action to pass the EPIC Act. Read the full letter.